DrugDashboards

Doxorubicin Hydrochloride Liposome

Doxorubicin Hydrochloride · DOXORUBICIN HYDROCHLORIDE 2 mg/mL · Injection, Suspension, Liposomal · Intravenous · Sagent Pharmaceuticals

NDC 25021-0263-10 · 1 VIAL in 1 CARTON / 10 mL in 1 VIAL · ANDA · View full market →

The short version

9 companies supply this market — a reasonable cushion if one runs into trouble.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Medicare Part B (ASP)

Payment limit per 10 MG
$116.605
HCPCS Q2050 · Jul 1, 2026 quarter · typically ASP + 6%

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

Is this a "specialty" drug?

There's no legal definition — it meets 1 of 6 public criteria. Why that matters →

  • Part D specialty tier
  • Costs ≥ $950/fill
  • Biologic (BLA)
  • Injectable / infused
  • Orphan-drug exclusivity
  • REMS program

Regulatory

Application
ANDA219881
TE code
AB
Approval date
Feb 3, 2026
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Doxorubicin Hydrochloride (Injection, Suspension, Liposomal)

LabelerStrengthFirst seenLast seen
Alembic Pharmaceuticals Inc.DOXORUBICIN HYDROCHLORIDE 2 mg/mLJul 15, 2026Sep 3, 2026
Baxter Healthcare CompanyDOXORUBICIN HYDROCHLORIDE 2 mg/mLJul 15, 2026Sep 3, 2026
BluePoint LaboratoriesDOXORUBICIN HYDROCHLORIDE 2 mg/mLJul 15, 2026Sep 3, 2026
Dr. Reddy's Laboratories Inc.DOXORUBICIN HYDROCHLORIDE 2 mg/mLJul 15, 2026Sep 3, 2026
Lupin Pharmaceuticals, Inc.DOXORUBICIN HYDROCHLORIDE 2 mg/mLJul 15, 2026Sep 3, 2026
GlaxoSmithKline Manufacturing SpADOXORUBICIN HYDROCHLORIDE 2 mg/mLJul 15, 2026Sep 2, 2026
Sagent PharmaceuticalsDOXORUBICIN HYDROCHLORIDE 2 mg/mLJul 15, 2026Sep 2, 2026
Alembic Pharmaceuticals LimitedDOXORUBICIN HYDROCHLORIDE 2 mg/mLJul 15, 2026Aug 31, 2026
Baxter Healthcare CorporationDOXORUBICIN HYDROCHLORIDE 2 mg/mLJul 15, 2026Aug 28, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Doxorubicin Hydrochloride Liposome — NDC 25021-0263-10," retrieved September 3, 2026, https://drugdashboards.com/drug/25021026310.

Free to cite with attribution — see how the data is put together.